Rheumatology Therapeutics Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028
Rheumatology is a branch of medicine dedicated to the diagnosis and therapy of rheumatic diseases. Rheumatology therapeutics involve physical therapies, exercises, and medications with surgical treatment to cure joint damage. Scleroderma, fibromyalgia, gout, osteoarthritis, reactive arthritis, psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis are some common types of rheumatology diseases. Thus, with the increasing burden of rheumatology diseases worldwide, the demand for rheumatology therapeutics is also increasing. According to the Centers for Disease Control and Prevention (CDC), by 2040, around 78 million adults in the United States aged 18 years or older are expected to have doctor-diagnosed arthritis. The aforementioned factors are expected to augment the rheumatology therapeutics market growth. Moreover, doctors prescribe disease-modifying antirheumatic drugs (DMARDs) for the treatment of rheumatologic disease. For example, in April 2021, Nēsos receiv...